As of December 23, 2024, the average one-year price target for Voyager Therapeutics is $17.44/share. The forecasts range from a low of $11.11 to a high of $31.50. The average price target ...

Zacks Analyst Bullish On Gene Therapy-Focused Voyager Therapeutics Sees Best In Class Potential For Its Neurogenetic Medicine Platform Unlock potential with Voyager Therapeutics as HC Wainwright ...

Voyager Therapeutics, Inc. is a clinical-stage gene therapy company, which engages in the development of treatments for severe neurological diseases. Its pipeline of gene therapy programs includes ...